Recalls & Warnings April 06, 2016 FDA Warns of Stimulant Methylsynephrine In Supplements On March 31, 2016, the FDA issued warning letters to seven companies selling products containing methylsynephrine (also called p-hydroxyephedrine or Oxilofrine), a stimulant drug which is not permitted in dietary supplements in the U.S
To view a copy of this license, visit About this article Cite this article Song, J., Yu, Y., Xing, R
doi: 10.1002/hep.28431 58
[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Yan Y., Liang H., Yang S., Wang J., Xie L., Qin X., Li S
"2021 International Sports Hall of Fame Inductees"
Warnings Do Not Take With : Other detoxification treatments or medications without consulting a healthcare provider, as there may be interactions, especially with Activated Charcoal